Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 4, 1997

View Archived Issues

Sepracor's levalbuterol NDA accepted by FDA

ICOS and Abbott expand collaboration

Vertex and Alpha Therapeutic end hemoglobin collaboration

Anika completes phase III trial on Orthovisc

Activated Cell Therapy now named Dendreon Corporation

SmithKline Beecham and Incyte form diaDexus

Improved IOP-lowering prostaglandin analogues from Alcon

DuPont Merck discloses new anticoagulants

Large, long-term trial evaluates association between heart rate and mortality

Role of vitamin C in cardiovascular diseases investigated

Lipoprotein(a): new insights into the process of atherosclerosis

Subtype-selective NMDA receptor ligands reported

CV Therapeutics: Q2 1997 highlights

Celltech prepares PDE IV inhibitors

Vitronectin receptor antagonists described by Merck KGaA

Nippon Roche: products under development

DANAMI trial results presented

Texas Biotechnology: Q2 1997 highlights

Merck's asthma treatment receives first approvals

Genzyme General's Seprafilm receives approval in Japan

Neurobiological Technologies files IND for antiedema agent

AccuSite approved in Ireland and The Netherlands

Spotlight on adenosine A1 receptor agonists

DepoTech seeks Canadian approval for DepoCyt

Xoma: Q2 1997 highlights

NeuroSearch compound enters phase I for treatment of dementia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...